Pure MHC logo

About Us

Pure MHC is a leading discovery and development company focused on identifying novel HLA peptide targets for oncology, infectious disease, and autoimmune indications.


Using a proprietary methodology, Pure MHC qualifies and quantifies the surface presence of HLA peptide targets using primary tissues and provides them to partners for therapeutic development. De novo discovery projects as well as an assortment of well-profiled targets for colorectal (CRC), non-small cell lung (NSCLC), and ovarian cancers are available now.



Team Members

Hildebrand 1

Willie Hildebrand

Chief Scientist

Kris Looney headshot

Kris Looney


2020_Curtis M_Headshot-min

Curtis McMurtrey

Director of Immunoproteomics